Krankenhauskosten und gesundheitsbezogene Lebensqualität bei Patienten mit Delir: ein Scoping-Review

Chris van Lieshout; Ewoud Schuit; Carsten Hermes; Matthew Kerrigan; Geert W J Frederix

doi:10.1016/j.zefq.2022.02.001

Krankenhauskosten und gesundheitsbezogene Lebensqualität bei Patienten mit Delir: ein Scoping-Review

Translated title of the contribution: Hospitalisation costs and health related quality of life in delirious patients: a scoping review

Chris van Lieshout
, Ewoud Schuit
, Carsten Hermes
, Matthew Kerrigan
, Geert W J Frederix

Research output: Contribution to journal › Review article › peer-review

20 Downloads (Pure)

Abstract

INTRODUCTION: Delirium is a common condition of a global disturbance of cognition, triggered by underlying diseases. The objective of this study is to review the current evidence in the literature on direct healthcare costs and health related quality of life (HRQOL) associated with delirium.

METHODS: A systematic search was conducted in PubMed and Embase for relevant studies published between January 1, 2010 and November 4, 2021. Studies for inclusion reported estimates on healthcare costs or HRQOL, adjusted for relevant confounding factors.

RESULTS: Fourteen studies on healthcare costs and eleven studies on HRQOL were included. Delirium resulted in (adjusted) increased costs ranging from $1,532 to $22,269 depending on included cost categories, the country and the type of hospital department. Increased length of stay for delirious patients ranged from 2.5 days to 10.4 days and had the largest contribution to overall, direct incremental costs. Heterogeneity was observed in HRQOL outcomes.

CONCLUSION: The analysis indicates that the presence of a delirium episode may lead to increased costs of hospitalisation. Changes in HRQOL due to delirium are not well demonstrated and more research is needed to determine the effect of delirium on HRQOL.

Translated title of the contribution	Hospitalisation costs and health related quality of life in delirious patients: a scoping review
Original language	German
Pages (from-to)	28-38
Number of pages	11
Journal	Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen
Volume	169
Early online date	11 Mar 2022
DOIs	https://doi.org/10.1016/j.zefq.2022.02.001
Publication status	Published - Apr 2022

Keywords

Cost Analysis
Delirium
Healthcare Costs
Quality of Life
Scoping Review

Access to Document

10.1016/j.zefq.2022.02.001Licence: CC BY

1-s2.0-S1865921722000265-mainFinal published version, 588 KBLicence: CC BY

Cite this

@article{24531eeb61b84a099b65e875b652ac5d,

title = "Krankenhauskosten und gesundheitsbezogene Lebensqualit{\"a}t bei Patienten mit Delir: ein Scoping-Review",

abstract = "INTRODUCTION: Delirium is a common condition of a global disturbance of cognition, triggered by underlying diseases. The objective of this study is to review the current evidence in the literature on direct healthcare costs and health related quality of life (HRQOL) associated with delirium.METHODS: A systematic search was conducted in PubMed and Embase for relevant studies published between January 1, 2010 and November 4, 2021. Studies for inclusion reported estimates on healthcare costs or HRQOL, adjusted for relevant confounding factors.RESULTS: Fourteen studies on healthcare costs and eleven studies on HRQOL were included. Delirium resulted in (adjusted) increased costs ranging from \$1,532 to \$22,269 depending on included cost categories, the country and the type of hospital department. Increased length of stay for delirious patients ranged from 2.5 days to 10.4 days and had the largest contribution to overall, direct incremental costs. Heterogeneity was observed in HRQOL outcomes.CONCLUSION: The analysis indicates that the presence of a delirium episode may lead to increased costs of hospitalisation. Changes in HRQOL due to delirium are not well demonstrated and more research is needed to determine the effect of delirium on HRQOL.",

keywords = "Cost Analysis, Delirium, Healthcare Costs, Quality of Life, Scoping Review",

author = "\{van Lieshout\}, Chris and Ewoud Schuit and Carsten Hermes and Matthew Kerrigan and Frederix, \{Geert W J\}",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = apr,

doi = "10.1016/j.zefq.2022.02.001",

language = "German",

volume = "169",

pages = "28--38",

journal = "Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen",

issn = "1865-9217",

publisher = "Elsevier",

}

TY - JOUR

T1 - Krankenhauskosten und gesundheitsbezogene Lebensqualität bei Patienten mit Delir

T2 - ein Scoping-Review

AU - van Lieshout, Chris

AU - Schuit, Ewoud

AU - Hermes, Carsten

AU - Kerrigan, Matthew

AU - Frederix, Geert W J

PY - 2022/4

Y1 - 2022/4

N2 - INTRODUCTION: Delirium is a common condition of a global disturbance of cognition, triggered by underlying diseases. The objective of this study is to review the current evidence in the literature on direct healthcare costs and health related quality of life (HRQOL) associated with delirium.METHODS: A systematic search was conducted in PubMed and Embase for relevant studies published between January 1, 2010 and November 4, 2021. Studies for inclusion reported estimates on healthcare costs or HRQOL, adjusted for relevant confounding factors.RESULTS: Fourteen studies on healthcare costs and eleven studies on HRQOL were included. Delirium resulted in (adjusted) increased costs ranging from $1,532 to $22,269 depending on included cost categories, the country and the type of hospital department. Increased length of stay for delirious patients ranged from 2.5 days to 10.4 days and had the largest contribution to overall, direct incremental costs. Heterogeneity was observed in HRQOL outcomes.CONCLUSION: The analysis indicates that the presence of a delirium episode may lead to increased costs of hospitalisation. Changes in HRQOL due to delirium are not well demonstrated and more research is needed to determine the effect of delirium on HRQOL.

AB - INTRODUCTION: Delirium is a common condition of a global disturbance of cognition, triggered by underlying diseases. The objective of this study is to review the current evidence in the literature on direct healthcare costs and health related quality of life (HRQOL) associated with delirium.METHODS: A systematic search was conducted in PubMed and Embase for relevant studies published between January 1, 2010 and November 4, 2021. Studies for inclusion reported estimates on healthcare costs or HRQOL, adjusted for relevant confounding factors.RESULTS: Fourteen studies on healthcare costs and eleven studies on HRQOL were included. Delirium resulted in (adjusted) increased costs ranging from $1,532 to $22,269 depending on included cost categories, the country and the type of hospital department. Increased length of stay for delirious patients ranged from 2.5 days to 10.4 days and had the largest contribution to overall, direct incremental costs. Heterogeneity was observed in HRQOL outcomes.CONCLUSION: The analysis indicates that the presence of a delirium episode may lead to increased costs of hospitalisation. Changes in HRQOL due to delirium are not well demonstrated and more research is needed to determine the effect of delirium on HRQOL.

KW - Cost Analysis

KW - Delirium

KW - Healthcare Costs

KW - Quality of Life

KW - Scoping Review

UR - https://www.scopus.com/pages/publications/85126324629

U2 - 10.1016/j.zefq.2022.02.001

DO - 10.1016/j.zefq.2022.02.001

M3 - Review article

C2 - 35288063

SN - 1865-9217

VL - 169

SP - 28

EP - 38

JO - Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen

JF - Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen

ER -

Krankenhauskosten und gesundheitsbezogene Lebensqualität bei Patienten mit Delir: ein Scoping-Review

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this